Home/Filings/4/0001562180-24-000328
4//SEC Filing

Umstead John W. V 4

Accession 0001562180-24-000328

CIK 0001560241other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 6:04 AM ET

Size

19.1 KB

Accession

0001562180-24-000328

Insider Transaction Report

Form 4
Period: 2024-01-03
Umstead John V.
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-01-03+74,50074,500 total
    Exercise: $2.97Exp: 2034-01-03Common Stock (74,500 underlying)
  • Sale

    Common Stock

    2024-01-04$2.94/sh111$327130,443 total
  • Award

    Common Stock

    2024-01-03+37,300131,186 total
  • Sale

    Common Stock

    2024-01-03$3.12/sh253$789130,933 total
  • Sale

    Common Stock

    2024-01-03$3.12/sh379$1,182130,554 total
Footnotes (10)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 3, 2025 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F10]The shares underlying this option vest as to 25% of the shares on January 3, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]Represents (i) 2,749 shares of common stock; (ii) 637 RSUs from award granted on January 4, 2021; (iii) 2,500 RSUs from award granted on January 3, 2022; (iv) 3,000 RSUs from award granted on January 3, 2023; (v) 50,000 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; and (vii) 37,300 RSUs from award granted on January 3, 2024.
  • [F4]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the Reporting Person.
  • [F5]The price represents the weighted average price with a low of $3.08 and a high of $3.16. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]Represents (i) 2,996 shares of common stock; (ii) 637 RSUs from award granted on January 4, 2021; (iii) 2,000 RSUs from award granted on January 3, 2022; (iv) 3,000 RSUs from award granted on January 3, 2023; (v) 50,000 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; and (vii) 37,300 RSUs from award granted on January 3, 2024.
  • [F7]Represents (i) 3,367 shares of common stock; (ii) 637 RSUs from award granted on January 4, 2021; (iii) 2,000 RSUs from award granted on January 3, 2022; (iv) 2,250 RSUs from award granted on January 3, 2023; (v) 50,000 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; and (vii) 37,300 RSUs from award granted on January 3, 2024.
  • [F8]The price represents the weighted average price with a low of $2.89 and a high of $3.00. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F9]Represents (i) 3,468 shares of common stock; (ii) 425 RSUs from award granted on January 4, 2021; (iii) 2,000 RSUs from award granted on January 3, 2022; (iv) 2,250 RSUs from award granted on January 3, 2023; (v) 50,000 RSUs from award granted on March 15, 2023; (vi) 35,000 RSUs from award granted on May 10, 2023; and (vii) 37,300 RSUs from award granted on January 3, 2024.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001967910

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 6:04 AM ET
Size
19.1 KB